Hari Sankaran

6PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2026
Risk of developing malignant peripheral nerve sheath tumors in patients with neurofibromatosis 1 receiving MEK inhibitor treatment for plexiform neurofibromas.

|Aug 07, 2026
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.

|Feb 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Alexander W Rankin, Regina M Myers, Adam J Lamble

|Sep 12, 2022
Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.

Hari Sankaran, Shanda R Finnigan, Lisa M McShane

|Nov 10, 2020
Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural products.

Julia Krushkal, Simarjeet Negi, Laura M Yee

|Jan 12, 2020
A comparison of asparaginase activity in generic formulations of E.coli derived L- asparaginase: In-vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia.

Hari Sankaran, Soumika Sengupta, Vaitashi Purohit

Pageof 1

Frequent Collaborators

2 joint publications

Lisa M McShane

2 joint publications

Nita L Seibel

1 joint publications

Julia Krushkal

1 joint publications

Laura M Yee